Connect with us

Business

Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX)

Published

on

Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX)

Hinde Group, an investment management company, has released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 14.37% (gross) and 13.93% (net) compared to 8.12% for the S&P 500 Total Return. The YTD return was 36.44% (gross) and 34.91% (Net) compared to 14.83% for the Index. The generative AI investment boom is a key reason the economy remains stable, and the stock market is optimistic despite ongoing political and economic challenges. You can check the fund’s top 5 holdings for its best picks for 2025.

In its third-quarter 2025 investor letter, Hinde Group highlighted stocks such as Becton, Dickinson and Company (NYSE:BDX). Becton, Dickinson and Company (NYSE:BDX) is a healthcare company that develops and manufactures medical supplies, devices, laboratory equipment, and diagnostic products. The one-month return of Becton, Dickinson and Company (NYSE:BDX) was 1.07%, and its shares lost 13.86% of their value over the last 52 weeks. On November 14, 2025, Becton, Dickinson and Company (NYSE:BDX) stock closed at $193.04 per share, with a market capitalization of $55.33 billion.

Hinde Group stated the following regarding Becton, Dickinson and Company (NYSE:BDX) in its third quarter 2025 investor letter:

Advertisement

“We initiated a long position in Becton, Dickinson and Company (NYSE:BDX) during the quarter. BDX is a special situation investment. It is our first new position since 2022.

Is Becton, Dickinson, and Company (BDX) the Best-Falling Stock to Buy According to Analysts?
Is Becton, Dickinson, and Company (BDX) the Best-Falling Stock to Buy According to Analysts?

Becton, Dickinson and Company (NYSE:BDX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 58 hedge fund portfolios held Becton, Dickinson and Company (NYSE:BDX) at the end of the second quarter, up from 54 in the previous quarter. In the fiscal fourth quarter of 2025, Becton, Dickinson and Company’s (NYSE:BDX) revenue grew 7% to $5.9 billion or 3.9% organic. While we acknowledge the potential of Becton, Dickinson and Company (NYSE:BDX) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered Becton, Dickinson and Company (NYSE:BDX) and shared FMI’s views on the company. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.

Advertisement

Source link

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2025 Wordupnews.com